Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
26.40
+0.18 (0.69%)
Nov 21, 2024, 4:00 PM EST - Market closed
Royalty Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$41.67
Upside
+57.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +51.52% | Oct 25, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $50 → $51 | Strong Buy | Maintains | $50 → $51 | +93.18% | Aug 14, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $51 | Buy | Maintains | $48 → $51 | +93.18% | Jul 11, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $28 | Strong Buy → Hold | Downgrades | $28 | +6.06% | Jun 3, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $40 → $38 | Strong Buy | Maintains | $40 → $38 | +43.94% | Apr 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $45 → $42 | Buy | Maintains | $45 → $42 | +59.09% | Feb 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $56 → $50 | Strong Buy | Maintains | $56 → $50 | +89.39% | Feb 20, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $54 → $57 | Buy | Maintains | $54 → $57 | +115.91% | Nov 9, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $53 → $54 | Buy | Maintains | $53 → $54 | +104.55% | Oct 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $52 → $53 | Buy | Maintains | $52 → $53 | +100.76% | Aug 9, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $52 | Buy | Reiterates | $52 | +96.97% | Jul 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $50 → $52 | Buy | Maintains | $50 → $52 | +96.97% | May 10, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +89.39% | Apr 10, 2023 |
| Tigress Financial | Tigress Financial | Strong Buy Reiterates $57 → $60 | Strong Buy | Reiterates | $57 → $60 | +127.27% | Apr 6, 2023 |
| UBS | UBS | Strong Buy Maintains $51 → $48 | Strong Buy | Maintains | $51 → $48 | +81.82% | Feb 16, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $54 → $51 | Buy | Maintains | $54 → $51 | +93.18% | Dec 6, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.